WST West Pharmaceutical Services, Inc.
Healthcare$316.42+0.09%ClosedMarket Cap: $22.35B
As of 2026-05-25
Valuation
P/E (TTM)
37.83
PEG
186.41
P/B
7.62
P/S
6.94
EV/EBITDA
27.72
DCF Value
$93.35
FCF Yield
2.0%
Div Yield
0.3%
Margins & Returns
Gross Margin
36.2%
Operating Margin
20.7%
Net Margin
16.9%
ROE
17.9%
ROA
13.2%
ROIC
15.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $844.9M | 35.1% | $177.1M | $138.8M | $— | $0.22 |
| Q4 null | $805.0M | 37.8% | $156.6M | $132.1M | $— | $0.22 |
| FY null | $3.07B | 35.9% | $617.4M | $493.7M | $— | $0.85 |
| Q3 null | $804.3M | 36.5% | $173.7M | $140.0M | $— | $0.21 |
| Q2 null | $766.2M | 35.7% | $158.2M | $131.8M | $— | $0.21 |
| Q1 null | $698.2M | 33.3% | $128.4M | $89.8M | $— | $0.21 |
| Q4 null | $748.5M | 36.7% | $170.6M | $130.1M | $— | $0.21 |
| FY null | $2.89B | 34.6% | $594.6M | $492.7M | $— | $0.81 |
| Q3 null | $746.9M | 35.5% | $167.8M | $136.0M | $— | $0.20 |
| Q2 null | $702.0M | 32.9% | $130.8M | $111.3M | $— | $0.20 |
| Q1 null | $695.3M | 33.3% | $127.0M | $115.3M | $— | $0.20 |
| Q4 2023 | $732.1M | 38.1% | $170.6M | $137.0M | $1.83 | $0.20 |